+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Tests for Alzheimer's Diagnosis Market - Global Forecast 2026-2032- Product Image
Blood Tests for Alzheimer's Diagnosis Market - Global Forecast 2026-2032- Product Image
Sale

Blood Tests for Alzheimer's Diagnosis Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081251
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Tests for Alzheimer's Diagnosis Market is projected to reach USD 524.18 Million in 2026. It is expected to continue growing at a CAGR of 13.18%, reaching USD 1.10 Billion by 2032.

Blood Tests for Alzheimer’s Diagnosis: Executive Overview

Blood tests for Alzheimer’s diagnosis are advancing from research applications toward clinical decision support. The field centers on detecting blood-based biomarkers associated with amyloid pathology, tau pathology, and neurodegeneration, while improving accessibility compared with cerebrospinal fluid analysis and imaging. Clinical value depends on analytical validity, diagnostic accuracy, appropriate patient selection, and integration with specialist assessment rather than use as a standalone diagnosis.

Diagnostic Practice Is Shifting Toward Earlier, Less Invasive Assessment

The landscape is being transformed by more sensitive plasma assays, standardized biomarker definitions, and growing emphasis on biologically defined Alzheimer’s disease. Blood testing can support triage, reduce reliance on invasive procedures, and help prioritize confirmatory testing, but implementation requires validated cutoffs, quality controls, clear referral pathways, and safeguards against inappropriate testing. Regulators and health systems are also placing greater weight on clinical utility, patient communication, and equitable access.

Artificial Intelligence Strengthens Interpretation, Validation, and Workflow Integration

Artificial intelligence can combine plasma biomarkers with age, symptoms, cognitive measures, imaging, and medical history to improve risk stratification and identify cases requiring confirmatory evaluation. It can also support assay quality monitoring, laboratory workflow optimization, and interpretation of longitudinal results. However, algorithmic performance may vary across populations, laboratories, and disease stages. Transparent validation, calibration, privacy protection, human oversight, and monitoring for demographic bias remain essential before AI-supported outputs influence care.

Regional Insights: Adoption Depends on Infrastructure, Regulation, and Access

North America is characterized by strong biomarker research, specialist infrastructure, and active clinical translation, alongside attention to reimbursement and regulatory evidence. Europe emphasizes harmonized standards, privacy, and integration with memory-clinic pathways, while the Middle East is developing specialized diagnostic capacity unevenly across health systems. Asia-Pacific combines advanced laboratory ecosystems in some economies with substantial variation in access and validation resources. Latin America faces differences in laboratory capacity, affordability, and specialist availability, and Africa requires approaches suited to limited infrastructure, underrepresentation in datasets, and broader diagnostic-access constraints.

Group Insights: Multilateral Alignment Can Improve Responsible Deployment

ASEAN priorities include interoperable laboratory practices and scalable access across diverse health systems. BRICS members may benefit from collaborative validation studies and locally representative reference data. The European Union places emphasis on evidence standards, data governance, and cross-border health integration. G7 systems are positioned to advance clinical validation, reimbursement frameworks, and workforce training. GCC countries can leverage centralized health infrastructure while addressing population diversity, and NATO members may contribute to resilient laboratory networks, research collaboration, and secure data practices.

Country Insights: National Readiness Varies Across the Diagnostic Pathway

Australia, Canada, France, Germany, Italy, Spain, the United Kingdom, and the United States have substantial research, specialist, or laboratory capabilities, but differ in regulatory pathways, reimbursement, and care integration. China, India, Japan, and South Korea are expanding biomarker research and diagnostic capacity while addressing population diversity, clinical standardization, and access. Brazil and Mexico face opportunities to broaden specialist referral networks and laboratory availability. Russia’s implementation environment is shaped by domestic research capacity, healthcare infrastructure, and access to validated technologies. Across all countries, responsible adoption requires local evidence, clinician education, and clear patient consent.

Action Priorities for Leaders Building Trustworthy Blood-Based Diagnosis

Industry leaders should prioritize analytically validated assays, clinically meaningful endpoints, and prospective studies across diverse populations. They should establish transparent performance claims, external quality assessment, and clear instructions for interpreting indeterminate results. Partnerships with laboratories, memory clinics, regulators, and patient groups can support workflow design and informed consent. Leaders should also plan for data governance, cybersecurity, affordability, clinician training, and post-deployment monitoring, while positioning blood tests as part of a diagnostic pathway rather than a replacement for comprehensive assessment.

Research Methodology: Evidence-Centered Assessment of the Diagnostic Ecosystem

This executive summary uses the defined market scope of blood tests for Alzheimer’s diagnosis and synthesizes established considerations across biomarker science, assay performance, clinical workflows, regulation, health-system readiness, and responsible AI use. Regional, group, and country perspectives are framed qualitatively around infrastructure, access, research activity, governance, and implementation conditions. No market estimates, market shares, forecasts, or company-specific claims are included. Interpretation should be updated as clinical guidelines, regulatory decisions, and validation evidence evolve.

Conclusion: Clinical Utility and Equity Will Determine Lasting Impact

Blood tests have the potential to make Alzheimer’s assessment more accessible, scalable, and biologically informed. Their lasting role will depend on reproducible assays, representative validation, appropriate clinical pathways, and honest communication of uncertainty. Health systems and industry leaders that combine scientific rigor with equitable implementation, privacy protection, and clinician oversight will be best placed to translate technological progress into trusted patient benefit.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Tests for Alzheimer's Diagnosis Market, by Technology
7.1. Introduction
7.2. Immunoassay
7.2.1. ELISA
7.2.2. SIMOA
7.3. Mass Spectrometry
7.4. Point Of Care Testing
8. Blood Tests for Alzheimer's Diagnosis Market, by Sample Type
8.1. Introduction
8.2. Plasma
8.3. Serum
8.4. Whole Blood
9. Blood Tests for Alzheimer's Diagnosis Market, by End User
9.1. Introduction
9.2. CROs
9.3. Diagnostic Laboratories
9.4. Hospitals
9.5. Research Institutes
10. Blood Tests for Alzheimer's Diagnosis Market, by Disease Stage
10.1. Introduction
10.2. Alzheimer's Dementia
10.3. Mild Cognitive Impairment
10.4. Preclinical
11. Blood Tests for Alzheimer's Diagnosis Market, by Application
11.1. Introduction
11.2. Disease Monitoring
11.3. Drug Development
11.4. Early Detection
11.5. Prognosis
12. Blood Tests for Alzheimer's Diagnosis Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Blood Tests for Alzheimer's Diagnosis Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Blood Tests for Alzheimer's Diagnosis Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Alamar Biosciences
16.3. ALZpath
16.4. Beckman Coulter
16.5. Bio-Rad Laboratories Inc
16.6. Bio-Techne
16.7. C2N Diagnostics Inc
16.8. Eisai Co Ltd
16.9. Eli Lilly and Company
16.10. Fujirebio Diagnostics Inc
16.11. Janssen Pharmaceuticals
16.12. Labcorp
16.13. Lupin Limited
16.14. Novartis AG
16.15. Pfizer Inc
16.16. Quanterix Corporation
16.17. Quest Diagnostics Incorporated
16.18. Roche Diagnostics GmbH
16.19. Siemens Healthineers AG
16.20. Sysmex Corporation
16.21. Thermo Fisher Scientific
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Blood Tests for Alzheimer's Diagnosis Market, Years Considered for the Study
FIGURE 2. Global Blood Tests for Alzheimer's Diagnosis Market, Research Design
FIGURE 3. Global Blood Tests for Alzheimer's Diagnosis Market, Research Framework
FIGURE 4. Global Blood Tests for Alzheimer's Diagnosis Market, Data Triangulation
FIGURE 5. Global Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 9. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2025 vs 2032 (%)
FIGURE 13. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Blood Tests for Alzheimer's Diagnosis Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Blood Tests for Alzheimer's Diagnosis Market Segmentation & Coverage
TABLE 2. Global Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 3. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global SIMOA Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global SIMOA Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global SIMOA Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Point Of Care Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Point Of Care Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Point Of Care Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 20. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 30. Global CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 43. Global Alzheimer's Dementia Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Alzheimer's Dementia Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Alzheimer's Dementia Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Mild Cognitive Impairment Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Mild Cognitive Impairment Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Mild Cognitive Impairment Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Preclinical Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Preclinical Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Preclinical Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 53. Global Disease Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Disease Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Disease Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Drug Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Drug Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Drug Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Early Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Early Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Early Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Prognosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Prognosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Prognosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. North America Blood Tests for Alzheimer's Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. North America Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 75. North America Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 76. North America Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 77. North America Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. North America Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 79. North America Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Latin America Blood Tests for Alzheimer's Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Latin America Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 82. Latin America Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 83. Latin America Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 84. Latin America Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Latin America Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 86. Latin America Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. Europe Blood Tests for Alzheimer's Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Europe Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 89. Europe Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 90. Europe Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 91. Europe Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Europe Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 93. Europe Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Middle East Blood Tests for Alzheimer's Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Middle East Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 96. Middle East Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 97. Middle East Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 98. Middle East Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Middle East Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 100. Middle East Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. Africa Blood Tests for Alzheimer's Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Africa Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 103. Africa Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 104. Africa Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 105. Africa Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Africa Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 107. Africa Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN Blood Tests for Alzheimer's Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. ASEAN Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 112. ASEAN Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 113. ASEAN Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. ASEAN Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 115. ASEAN Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. GCC Blood Tests for Alzheimer's Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. GCC Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 118. GCC Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 119. GCC Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 120. GCC Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. GCC Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 122. GCC Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. European Union Blood Tests for Alzheimer's Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. European Union Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 125. European Union Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 126. European Union Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 127. European Union Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. European Union Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 129. European Union Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. BRICS Blood Tests for Alzheimer's Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. BRICS Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. BRICS Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 133. BRICS Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 134. BRICS Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. BRICS Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 136. BRICS Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. G7 Blood Tests for Alzheimer's Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. G7 Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 139. G7 Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 140. G7 Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 141. G7 Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. G7 Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 143. G7 Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. NATO Blood Tests for Alzheimer's Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. NATO Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 146. NATO Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 147. NATO Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 148. NATO Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. NATO Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 150. NATO Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Global Blood Tests for Alzheimer's Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. United States Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 153. United States Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. United States Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 155. United States Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 156. United States Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. United States Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 158. United States Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. Canada Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 160. Canada Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 161. Canada Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 162. Canada Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 163. Canada Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Canada Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 165. Canada Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. Mexico Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 167. Mexico Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. Mexico Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 169. Mexico Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 170. Mexico Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Mexico Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 172. Mexico Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. Brazil Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 174. Brazil Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 175. Brazil Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 176. Brazil Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 177. Brazil Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Brazil Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 179. Brazil Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 181. United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 182. United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 183. United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 184. United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 186. United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Germany Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 188. Germany Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. Germany Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 190. Germany Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 191. Germany Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Germany Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 193. Germany Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. France Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 195. France Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. France Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 197. France Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 198. France Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. France Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 200. France Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Russia Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 202. Russia Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. Russia Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 204. Russia Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 205. Russia Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Russia Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 207. Russia Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Italy Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 209. Italy Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. Italy Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 211. Italy Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 212. Italy Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Italy Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 214. Italy Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. Spain Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 216. Spain Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. Spain Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 218. Spain Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 219. Spain Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Spain Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 221. Spain Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. China Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 223. China Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. China Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 225. China Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 226. China Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. China Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 228. China Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. India Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 230. India Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 231. India Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 232. India Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 233. India Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. India Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 235. India Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Japan Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 237. Japan Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. Japan Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 239. Japan Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 240. Japan Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Japan Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 242. Japan Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. Australia Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 244. Australia Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 245. Australia Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 246. Australia Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 247. Australia Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Australia Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 249. Australia Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. South Korea Blood Tests for Alzheimer's Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 251. South Korea Blood Tests for Alzheimer's Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 252. South Korea Blood Tests for Alzheimer's Diagnosis Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 253. South Korea Blood Tests for Alzheimer's Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 254. South Korea Blood Tests for Alzheimer's Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. South Korea Blood Tests for Alzheimer's Diagnosis Market Size, by Disease Stage, 2017-2032 (USD Million)
TABLE 256. South Korea Blood Tests for Alzheimer's Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 257. Global Blood Tests for Alzheimer's Diagnosis Market Share, by Key Player, 2025
TABLE 258. Global Blood Tests for Alzheimer's Diagnosis Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Alamar Biosciences
  • ALZpath
  • Beckman Coulter
  • Bio-Rad Laboratories Inc
  • Bio-Techne
  • C2N Diagnostics Inc
  • Eisai Co Ltd
  • Eli Lilly and Company
  • Fujirebio Diagnostics Inc
  • Janssen Pharmaceuticals
  • Labcorp
  • Lupin Limited
  • Novartis AG
  • Pfizer Inc
  • Quanterix Corporation
  • Quest Diagnostics Incorporated
  • Roche Diagnostics GmbH
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific

Related Topics

Related Reports

Alzheimer's Blood Tests Market - Global Forecast 2026-2032 - Product Image

Alzheimer's Blood Tests Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Alzheimer's Disease Diagnosis Market - Global Forecast 2026-2032 - Product Image

Alzheimer's Disease Diagnosis Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Blood-Based Biomarker for Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis by Type, Technology, End-Use, Region, and Growth Forecasts, 2026-2033 - Product Image

Blood-Based Biomarker for Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis by Type, Technology, End-Use, Region, and Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis Report by Diagnostics Technique (Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests), Type (Triage, Diagnosis, Screening), End User, and Region with Growth Forecasts, 2026-2033 - Product Image

Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis Report by Diagnostics Technique (Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests), Type (Triage, Diagnosis, Screening), End User, and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Alzheimer's Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Alzheimer's Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.